Pfizer Inc (PFE)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 43,333,000 74,012,000 73,347,000 50,078,000 51,259,000 70,403,000 67,466,000 54,420,000 59,693,000 57,900,000 48,814,000 39,533,000 35,067,000 47,739,000 46,424,000 34,738,000 32,803,000 33,459,000 47,073,000 45,290,000
Total current liabilities US$ in thousands 47,794,000 31,136,000 34,647,000 36,562,000 42,138,000 44,314,000 47,410,000 39,268,000 42,671,000 41,803,000 35,664,000 26,652,000 25,920,000 34,154,000 32,723,000 33,890,000 37,304,000 36,974,000 32,030,000 29,423,000
Current ratio 0.91 2.38 2.12 1.37 1.22 1.59 1.42 1.39 1.40 1.39 1.37 1.48 1.35 1.40 1.42 1.03 0.88 0.90 1.47 1.54

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $43,333,000K ÷ $47,794,000K
= 0.91

The current ratio for Pfizer Inc. has exhibited variability over the past eight quarters. In Q4 2023, the current ratio stands at 0.91, indicating that the company may have difficulties meeting its short-term liabilities with current assets alone. This marks a significant drop from the previous quarter's current ratio of 2.38, representing a potential liquidity concern.

The current ratio had shown improvement in Q2 and Q3 2023 compared to the previous quarters, reaching values of 2.12 and 1.37, respectively. These ratios were above the commonly desired benchmark of 1, suggesting a strong ability to cover short-term obligations with current assets.

In comparison to the current ratio in Q4 2022, which was 1.22, the recent decline may raise questions about Pfizer Inc.'s liquidity position. It is worth noting that the current ratio fluctuated between 1.39 and 1.59 during the first two quarters of 2022 before trending downwards.

Overall, the current ratio trend for Pfizer Inc. indicates some volatility, with recent quarters showing both improvements and declines in liquidity position. Further analysis in conjunction with other financial metrics would be recommended to gain a comprehensive understanding of the company's financial health.


Peer comparison

Dec 31, 2023


See also:

Pfizer Inc Current Ratio (Quarterly Data)